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A study by Epelman et al. (2014) in this issue of Immunity demonstrates that diverse subpopulations of
macrophages reside in the adult heart and can be maintained by multiple mechanisms involving both local
proliferation and contributions from monocytes.Macrophages are found in virtually every
tissue of the body and exhibit remarkable
plasticity, allowing them to participate in
a variety of functions essential to the
survival of the host including defense
against pathogens, fetal and tissue
development, metabolism, and wound
healing (Wynn et al., 2013). Because of
their functional heterogeneity and the
diversity of niches in which these cells
reside, macrophages represent a poten-
tially powerful target for an expansive list
of diseases. Thus, how these tissue-resi-
dent phagocytes develop and are main-
tained throughout life remains an area
under intense investigation and debate.
The traditional model of macrophage
development was that blood monocytes
gave rise to all tissue macrophages.
Recently, multiple groups have unveiled
that many resident populations can be
established prenatally, persist through
adulthood, and self-renew in situ without
input from circulating monocytes. Thus,
our understanding of macrophage devel-
opment within tissues is under continuous
revision. Sophisticated in vivo fate-
mapping and lineage-tracing studies
employed by numerous groups have re-
vealed two distinct origins of myelopoie-
sis. The earliest macrophage precursors
originate from the extra-embryonic yolk
sac (YS) between E7.0 and E9.0. As the
embryo begins to develop blood vessels
and the aorta-gonad-mesonephros
(AGM) area, hematopoietic stem cells
(HSCs) are generated and colonize the
fetal liver and eventually the bonemarrow.
Thus, there are at least two mechanisms
of establishing resident macrophage
populations prior to birth. Much of what
is known about macrophage develop-
ment has been observed under steady-
state conditions, and the field has been
dominated by studies in the liver and
brain (Kupffer cells and microglia, respec-tively) (Ginhoux et al., 2010; Hume et al.,
1984; Klein et al., 2007; Schulz et al.,
2012; Yona et al., 2013). However, the
origins of macrophages residing in other
tissues remain incompletely understood.
Perhaps no other organ is more elusive
with regard to macrophage development
than the heart. In this issue of Immunity,
Epelman and colleagues (Epelman et al.,
2014) reveal the relative contributions
of hematopoietic and YS-derived macro-
phages in the heart and define the
mechanisms supporting macrophage
homeostasis at steady state and during
cardiac stress. Their findings provide
interesting contrasts with macrophage
biology in other organs during homeo-
stasis and inflammation.
After myocardial injury, the number of
macrophages increases, which is impor-
tant for the progression and resolution of
tissue injury; however, the relative hetero-
geneity and ontology of these cells was
unknown. Epelman et al. first gated on
cardiac macrophages (F4/80+CD11b+) to
show there are four different subpopula-
tions, which are distinct from blood
monocytes and dendritic cells (Figure 1).
The majority of myocardial macrophages
were CCR2Ly6C, which could be
further subdivided based on MHCII ex-
pression. The third macrophage subset
was CCR2Ly6C+ and the fourth resident
cardiac population expressed both CCR2
and Ly6C. By using parabiotic mice and
fetal liver HSC adoptive-transfer experi-
ments, the authors demonstrate little
or no replacement of the major cardiac
macrophage subsets with monocytes
derived from blood or fetal liver HSCs.
This suggests that the majority of the
resident (CCR2Ly6CCD11cLo) cardiac
macrophages are autonomously main-
tained. The homeostatic proliferation of
cardiac macrophages independent of
definitive hematopoiesis is consistentImmunitywith observations made in other tissues
(Hashimoto et al., 2013; Yona et al.,
2013). However, this blanket statement
regarding a lack of monocyte involvement
apparently cannot be unconditionally
applied to all cardiac macrophages.
Indeed monocytes appear to be critically
important for replenishing the minor,
Ly6C+ macrophage subsets in the heart.
Moreover, after macrophage depletion,
Ly6C+ monocytes had the capacity to
differentiate into all four cardiac macro-
phage subsets, thereby suggesting that
when homeostasis is disrupted, circu-
lating monocytes might serve as an
alternative source to repopulate long-
lasting myocardial resident macrophages
and restore balance within the macro-
phage compartment of the heart. This
finding is in contrast to what has been
observed in other tissues, where mono-
cytes were shown to play an insignificant
role in the repopulation of resident
macrophages.
The authors went on to show that under
inflammatory conditions following angio-
tensin II (AngII) infusion, Ly6Chi mono-
cytes can also be recruited to differentiate
into the multiple macrophage subsets.
Once reestablished however, the major
resident cardiac macrophage popula-
tions proliferated in situ, independent of
circulating monocytes, similar to what
has been observed by others in different
inflammatory tissues (Hashimoto et al.,
2013; Jenkins et al., 2011). Moreover,
the minor subsets also expanded
following AngII infusion but required
continuous monocyte input. Thus, the
replenishment of the multiple resident
macrophages following cardiac stress
relies on: (1) recruitment of peripheral
monocytes and (2) autonomous prolife-
ration (Figure 1). Therefore, statements
defining monocyte contribution to the
maintenance of tissue macrophages as40, January 16, 2014 ª2014 Elsevier Inc. 3
Figure 1. Origins and Dynamics of Resident Macrophage Subsets in the Adult Heart
Resident myocardial macrophages can be divided into two distinct pools. Themost abundant populations
originate from yolk sac progenitors, are able to self-renew, and are CCR2Ly6C. This population can be
further dissected into MHCIIhi (shown in green) and MHCIIlo (shown in yellow). The second, smaller pool of
resident cardiac macrophages is developmentally dependent on HSC-derived precursors and circulating
monocytes for maintenance under steady state conditions. These cells can be further subdivided into
CCR2 (shown in blue) and CCR2+ (shown in brown) populations. Although, LyC resident macrophages
do not depend on circulating monocytes for maintenance under homeostatic conditions (left), during
cardiac stress (right), recruited Ly6C+ blood monocytes can differentiate into all resident cardiac macro-
phage subsets, which can subsequently expand and proliferate, thus restoring homeostasis within the
macrophage compartment of the heart by two distinct mechanisms: local proliferation and HSC-derived
engraftment.
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Previewseither negligible or transient should be
avoided unless referring to specific tissue
locations, such as the gut, where these
events have been carefully analyzed
(Zigmond et al., 2012).
The authors next explored the onto-
logical origins of macrophages within
myocardial tissue. Genetic lineage-
tracing analysis revealed that primitive
macrophages seeded the heart as early
as E9.5–E10.5 via FLT3-independent
pathways and persisted in the adult heart
at even 20 weeks. However, a second
wave of macrophages appeared in the
heart that originated from fetal liver
HSCs, through a mix of FLT3-dependent
and -independent mechanisms. The ob-
servation of a subset of cardiac macro-
phages to arise independent of both
the YS and FLT3 is paradoxical because
FLT3 is an established marker of defini-
tive HSCs. Thus, there appears to be
an alternative pathway of myelopoiesis
stemming from the fetal liver that exists
independent of FLT3. Importantly, a
similar mix of YS- and HSC-derived
macrophages were observed in all other
tissues examined, except the brain, which
was completely seeded by YS-derived
progenitors. Fate mapping with CD115
reporter mice, in which YS-derived mac-
rophages are irreversibly fluorescently
labeled at E8.5, revealed that only the4 Immunity 40, January 16, 2014 ª2014 ElsevCCR2 resident macrophage subsets
were positively labeled in the adult heart.
Thus, myocardial macrophages are com-
posed of two distinct origins emanating
from both the YS and fetal liver. Surpris-
ingly, Epelman et al. indicated that
the only organs containing significant
numbers of YS-derived macrophages
are the brain, liver, and heart. This obser-
vation was unexpected because other
groups have showed that YS-derived
macrophages were more broadly found
among different tissues including the
lung, pancreas, spleen, peritoneum, and
kidney (Schulz et al., 2012; Yona et al.,
2013; Hashimoto et al., 2013). These
conflicting results might be attributed
to the use of different mouse reporter
strains to track YS-derived macrophages
or differences in the age of the embryo
when these promoters were induced.
Alternatively, other cell types or subsets
might compensate for the loss of indi-
vidual macrophage precursors targeted
for deletion, thereby potentially masking
a particular phenotype. Thus, although
debate continues about the origin of
individual macrophage types in tissue,
the observations in the present study
encourage careful consideration of the or-
gan system in question before making
blanket statements about the macro-
phages that reside in it.ier Inc.Whether YS-derived macrophages are
fundamentally different fromHSC-derived
macrophages remains controversial. The
development of macrophages from YS-
derived precursors appears to be an evo-
lutionally conserved process among
mammals, birds, and fish (Ginhoux et al.,
2010), implying a function that is vital for
embryonic development. Epelman and
colleagues perform elegant transcrip-
tional studies that illustrate interesting dif-
ferences in the various resident cardiac
macrophage subpopulations. The most
striking differences were in the expression
of genes associated with antigen presen-
tation and inflammatory pathways.
MHCIIhi cardiac macrophages more effi-
ciently presented antigen to T cells,
whereas MHCIIlo cells more effectively
phagocytosed particulate matter and
cellular debris. Furthermore, CCR2+ mac-
rophages more highly expressed NLRP3-
inflammsome associated genes and
secreted interleukin-1b following AngII
infusion in vivo, suggesting an inflamma-
tory role for this subset in response to car-
diac stress. Improving our understanding
of how cardiac resident macrophages
develop and are maintained is essential
for the future development of novel thera-
peutics to treat diseases in which cardiac
macrophages play an important part.
Therefore it will be important to address
whether these cardiac subsets observed
in mice mirror those in a human heart,
both with regard to phenotypic markers
and functional capabilities.
The work presented here is not only
important because it reveals the unex-
pected complexity of macrophages in
the heart, but also because it reinforces
the idea that there are precious few ‘‘ab-
solutes’’ when it comes to this remarkable
cell. Macrophages within one tissue can
be heterogeneous and can be derived
from hematopoietic precursors or from
primitive cells of the yolk sac. They can
either persist in an organ by local prolifer-
ation or depend on monocyte recruitment
for repopulation. Once in tissue, however,
macrophages appear to retain their plas-
ticity and not only change their own phys-
iology, but also alter the physiology of
cells adjacent to them. It will be a chal-
lenge for future studies to directly assess
whether HSC and YS-derived macro-
phages possess distinct functional
abilities in vivo under a variety of immuno-
logical and homeostatic threats and to
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lation dynamics in other unchartered
tissues.
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Invariant natural killer T cells are preactivated lymphocytes that react upon recognition of CD1d-antigen
complexes. Accordingly, any type of CD1d-positive cell could behave as antigen-presenting cell (APC).
In this issue of Immunity, Arora et al. (2014), report that professional APCs still make the difference.A mechanistic approach to antigen pre-
sentation has to consider individual
steps involved in final T cell stimulation.
Accordingly, different actors contribute
to antigen presentation, namely the
antigen-presenting cell (APC), the antigen
itself, and the responding T cell. Many
studies have defined the features that
provide superior competence of an APC;
thereby cells possessing these functions
are usually defined as ‘‘professional’’
APCs. Because T cells may recognize
proteins, lipids, and small metabolites as
antigens, professional APCs may deal
with chemically different antigens and
the talent possessed by APCs may be
different according to the type of pre-
sented antigen.
Presentation of lipid antigens is influ-
enced by the capacity to internalize and
bring lipids within the endosomal com-
partments where they encounter CD1
antigen-presenting molecules; to digest
lipids, if necessary, thus generating
smaller molecules that become morepalatable to efficient binding to CD1 mol-
ecules. The way of recycling of CD1-lipid
complexes defines the plasmamembrane
display of the complexes formed within
the APC, their pace of internalization
and lysosomal degradation. These latter
parameters directly impact antigen avail-
ability to T cell recognition. An important
issue, which remains poorly investigated,
is the display of the complexes within
defined plasma membrane domains. The
assembly of the CD1-lipid complexes
within membrane rafts, in packed do-
mains, or their dispersed distribution
ultimately affect the efficacy of antigen
recognition (Im et al., 2009). Two addi-
tional features deeply influencing T cell
responses are the availability on APCs
of costimulatory molecules interacting
with respective partner receptors dis-
played on T cells and the amounts of
CD1-presenting molecules expressed on
the surface of APC. Despite intense
efforts, we still do not know whether
unique costimulatory molecules areinvolved in lipid antigen presentation,
and we are slowly starting to comprehend
the mechanisms that control CD1 expres-
sion at epigenetic, transcriptional, and
posttranslational levels.
The second important actor of lipid
antigen presentation is the lipid antigen.
The lipid structure must obviously be
compatible with binding to CD1 mole-
cules. In some instances, an accurate
series of trimmings, which utilize a
variety of hydrolases, and probably also li-
pases, are required. The structures of lipid
antigens dictate their availability within
the extracellular environment and their
distribution to membranes of different
endosomal compartments. How lipid
antigens are extracted from membranes
and escorted until their insertion within
CD1 molecules also depends on lipid
structure. Lipid-binding proteins and
chaperones are important and their
redundancy remains unexplored.
The third actor is the T cell. T lympho-
cytes may directly influence the functions40, January 16, 2014 ª2014 Elsevier Inc. 5
